Product information and disease descriptionProduct descriptionProduct information
Dosing and administration
5 evidence topics · 6 sources
Metastatic castration-resistant prostate cancer previously treated with abiraterone, in combination with darolutamide
Product information and disease descriptionProduct descriptionProduct information
5 evidence topics · 6 sources